Blood concentration of propofol in a patient with delayed emergence from propofol-nitrous oxide anesthesia

Journal of Nippon Medical School

Volumn 72, Issue 5, 2005, Pages 300-303

  Shimada, Yoichi ^a   Suzuki, Manzo ^a   Fukuyo, Yasuaki ^a  

^a NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

Blood concentration; Delayed emergence; Propofol

Indexed keywords

ATROPINE; MEPIVACAINE; NEOSTIGMINE; NITROUS OXIDE; PROPOFOL; VECURONIUM;

AGED; ANEMIA; ANESTHESIA; ARTERY OCCLUSION; ARTICLE; BLOOD SAMPLING; CASE REPORT; CONSCIOUSNESS DISORDER; DRUG BLOOD LEVEL; DRUG CLEARANCE; EPIDURAL ANESTHESIA; GASTRECTOMY; HEPATIC ARTERY; HUMAN; LABORATORY TEST; LIVER DYSFUNCTION; MALE; PROTEIN BLOOD LEVEL; STOMACH CANCER;

AGED; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; HUMANS; MALE; NITROUS OXIDE; PROPOFOL;

EID: 27544466321     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.72.300     Document Type: Article

References (11)

1. Hiraoka H, Yamamoto K, Okano N, Morita T, Goto F, Horiuti R: Changes in drug plasma concentrations of extensively bound and high extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther 2004; 75: 324-330.
2. Veroli P, Okelly B, Bertrand F, Trouvin JH, Farinotti R, Ecoffey C: Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth 1992; 68: 183-186.
3. Sakamoto M, Oka S, Shimamoto C, Kin H, Kunimatsu T, Misaki T: Propofol induced awakening delay in two patients with liver dysfunction. J Clin Anesth (Jpn) 1998; 22: 1585-1587.
4. Koitabashi T, Satoh N, Takino Y: Delayed emergence from propofol, nitrous oxide and oxygen anesthesia. -a case report-. Masui 1997; 46: 975-977.
5. Shafer A, Dose VA, Shafer SL, White PF: Pharmacokinetics and phamacodynamics of propofol infusion during general anesthesia. Anesthesiology 1988; 69: 348-356.
6. Servin F, Cockshott ID, Farinotti R, Haberer JP, Winckler C, Desmonts JM: Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 1990; 65: 177-183.
7. Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R: Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 1988; 69: 887-891.
8. Takizawa D, Hiraoka H, Goto F, Yamamoto K, Horiuti R: Human kidneys play an important role in the elimination of propofol. Anesthesiology 2005; 102: 327-330.
9. Kazama T, Ikeda K, Morita K, Sanjo Y: Awaking propofol concentration with and without blood-effect site equilibration after short-term and long-term administration of propofol and fentanyl anesthesia. Anesthesiology 1998; 88: 928-934.
10. Mazoit JX, Samii K: Binding of propofol to blood components: implications for pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol 1999; 47: 35-42.
11. Yoshitani K, Kawaguchi M, Takahashi M, Kitaguchi K, Furuya H: Plasma propofol concentration and EEG burst suppression ration during normothermic cardiopulmonary bypass. BR J Anaesth 2003; 90: 122-126.